Healthtech Startups

Corra is a healthcare technology platform designed for individuals with rare and chronic health conditions, offering personalized and accessible health management tools.

1 investor

Correx develops a medical device system for aortic valve bypass surgery that automates the insertion process, enabling surgeons to perform the procedure on a beating heart without requiring a heart-lung machine. The system is designed for cardiac surgeons performing minimally invasive valve replacement procedures.

1 investor

CorroHealth develops revenue cycle management technology for healthcare organizations. The company provides solutions to optimize billing and financial processes in the healthcare industry.

1 investor

Cortene is developing a patent-protected, peptide-based drug targeting the brain signaling believed to underlie acquired chronic diseases such as Parkinson's, Alzheimer's, dysautonomia, autoimmunity, and ME/CFS. The company operates in biotech, focusing on the root causes of brain-centric chronic conditions.

1 investor

Cortex provides software for post-acute healthcare providers that generates follow-up care opportunities and tracks clinical outcomes. The platform sits alongside EHR systems to help post-acute providers manage patient care transitions and improve health outcomes.

1 investor

Cortical Dynamics develops a brain monitoring device (BARM™) that tracks anesthesia depth in real-time during surgical procedures, particularly for total intravenous anesthesia. The product is designed to improve patient outcomes and reduce the environmental impact of anesthesia administration in operating rooms.

1 investor

CortiCare provides remote continuous EEG monitoring as a virtual EEG department that supports hospital clinical teams rather than replacing them. Its quality assurance program sets standards for technologists, monitoring workflows, and clinical escalation to maintain consistent EEG monitoring across hospitals in the US.

1 investor

Cortirio develops a wearable infrared brain imaging headset for rapid detection of stroke and traumatic brain injury. The device provides portable, on-site diagnosis in under two minutes for clinical use.

1 investor

Cortrium develops a long-term ECG solution that combines wearable hardware, algorithms, and human expertise for recording and reporting to identify arrhythmias and prevent heart disease and stroke. It serves cardiology and healthcare professionals and their patients, operating across multiple countries through partners and distributors.

1 investor

CORU is Ireland's statutory health regulator responsible for registering and overseeing health and social care professionals including dietitians, physiotherapists, radiographers, and social workers. It establishes professional standards, approves education programs, maintains professional registers, and conducts disciplinary proceedings to protect public safety.

1 investor

CorVent Medical develops medical ventilators, including the RESPOND ventilator, that provide ICU-standard respiratory support for acute and post-acute patients. Its systems are designed for hospitals, clinics, and private care providers for both daily use and overflow or emergency situations.

1 investor

1 investor

Corvita develops automated external defibrillator (AED) solutions addressing gaps in emergency medical equipment for healthcare settings. The company combines hardware and management services to improve access to critical cardiac emergency response tools.

1 investor

Cosma is a women's health and fertility company that designs, manufactures and distributes non-hormonal fertility products for the Indian market, positioned as an option between unassisted conception and IVF. Its offerings include Fertigen, a CDSCO-approved Class B medical device, and FertiLens, a digital fertility assessment platform, supported by a network of fertility specialists, diagnostic labs and partner clinics.

1 investor

COSMIIC develops active implantable medical devices, including its Networked Neuroprosthesis (NNP) modular implant platform that stimulates muscles and records signals to restore function for people with disability and disease. It also provides resources to academic researchers to help translate implantable device concepts into systems tested in first-in-human studies.

1 investor

Cosmo Innovations develops LED light therapy and Photobiomodulation Therapy (PBMT) devices using red and blue light for beauty, health, and wellness applications such as skin repair, wound healing, and pain relief. The company positions its offering as a technology platform applicable to a range of uses, initially focused on aesthetic and wellness solutions.

1 investor

1 investor

Cothera Bioscience is a clinical-stage biopharmaceutical company developing small molecule therapies targeting previously undruggable oncology targets through synthetic lethality, protein degradation, and immunotherapy mechanisms. The company's lead candidates are in Phase 2 trials for hematologic malignancies and high-grade gliomas with specific genetic mutations.

1 investor

Cotiviti provides healthcare analytics and payment accuracy services aimed at improving financial performance, reducing inefficiency, and enhancing healthcare quality. It operates across North America, India, Canada, the United Kingdom, Australia, the Philippines, and Mexico.

1 investor

CoTreat provides AI-powered clinical documentation and patient communication tools for dental practices, automating consultation transcription, treatment planning, and patient letters. The platform helps dentists reduce administrative time while improving patient engagement through visualizations and structured care plans.

1 investor

Council Capital is a private equity firm focused on investing in healthcare services and healthcare IT sectors. The firm partners with portfolio companies to drive operational value creation and long-term growth in the healthcare industry.

1 investor

Counsyl was a clinical genetic-screening company offering DNA carrier screening for family planning, prenatal screening, and inherited cancer risk tests, processed in its own CLIA-certified lab. Co-founded in 2007 with Balaji Srinivasan as CTO, it screened hundreds of thousands of patients before Myriad Genetics acquired it for $375 million in 2018.

1 investor

Countable Labs (formerly Enumerix) develops Countable PCR, a DNA quantification technology that provides absolute target counts at single-molecule resolution as an alternative to qPCR, digital PCR, and NGS. Its genomics tools serve scientists working in biomarker analysis, gene therapeutics, and clinical diagnostics.

1 investor

Country Care Group supplies mobility and healthcare equipment and arranges in-home modifications for entitled veterans, war widow/ers and dependants under the Department of Veterans' Affairs Rehabilitation Appliances Program (RAP). It works with qualified health providers and a network of builders and tradesmen to deliver aids, appliances and home access improvements in Australia.

1 investor